Skip to main content
Clinical Trials/NCT05880342
NCT05880342
Recruiting
Phase 3

Investigating Fundamental Mechanisms of Mental and Physical Fatigue Using Neurotransmitter Reuptake Inhibitors and Electroencephalography: a Randomized Counterbalanced Crossover Trial

Vrije Universiteit Brussel1 site in 1 country62 target enrollmentMay 3, 2023

Overview

Phase
Phase 3
Intervention
Reboxetine Pill
Conditions
Fatigue
Sponsor
Vrije Universiteit Brussel
Enrollment
62
Locations
1
Primary Endpoint
Number of repetitions
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

The goal of this clinical trial is to determine the role of brain neurotransmission in the onset of fatigue, identify the brain areas involved, and determine how brain activity and neuromuscular efficiency changes during onset of fatigue. Three different experimental studies (physical fatigue, mental fatigue and combined) will be performed with a randomized, single-blinded, placebo controlled, counter-balanced, cross-over design.

The objectives of the projects are as follows:

  • To experimentally assess the role of a dopamine, and a noradrenalin reuptake inhibitor in the onset of exercise-induced fatigue
  • To identify changes in brain activation associated with altered PF and fatigue perception
  • To experimentally assess the effect of a NA or DA reuptake inhibitor on MF, brain activation and the sources of changes in brain activation
  • To experimentally assess the role of brain neurotransmitters (DA, NA) in the interaction between mental and PF from a neurophysiological perspective.

Participants will be healthy young adults. In each study, they will start with a familiarization trial followed by two experimental trials and one control trial with a randomized treatment order. At each visit, different drugs will be administered to elicit different neurotransmitter response. The trials will be performed at the MFYS exercise lab (BLITS, VUB campus Etterbeek, Boulevard General Jaques 271, 1050 Elsene (Brussels)).

Depending on the type of study they are participating in, participants will perform three distinct tasks:

  • In the first experimental study participants will perform a 60-min Stroop Task to elicit mental fatigue.
  • In the second experimental study participants will perform a knee-extension exercise until exhaustion to elicit physical fatigue.
  • In third experimental study participants will first preform a mental fatiguing task (Stroop taks) followed by physical fatigue task (knee extension).

While participants will perform above mentioned task their EEG signal and heart rate will be measured. At the same time, participants will report on their subjective feeling of fatigue during these tasks. In addition, all participants will be administered cognitive tasks before and after the study, along with questionnaires. In the second and third experiments, tensiomyography and electromyography will also be recorded from the quadriceps muscle of the leg used for knee extension.

Researchers will compare physiological and behavioural changes in response to specific neurotransmitter drug to answer the main question: what the role of a DA and a NA reuptake inhibitor on the onset of mental and physical fatigue is.

Registry
clinicaltrials.gov
Start Date
May 3, 2023
End Date
December 31, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yahaira Laurisa Arenales Arauz

Yahaira Laurisa Arenales Arauz

Vrije Universiteit Brussel

Eligibility Criteria

Inclusion Criteria

  • Healthy trained individuals (exercises at least 1x per week, no neurological, cardiovascular internal or musculoskeletal disorders of any kind)
  • No use of chronic or occasional prescribed medication (except for contraceptives)
  • Non-smoker

Exclusion Criteria

  • Injuries of any kind in the past 6 months
  • Pregnancy
  • Specific food or drink allergies (e.g. lactose and/or gluten intolerance)
  • Suffering from a chronic health condition (could be neurological, cardiovascular, internal and musculoskeletal)
  • Participating in any concomitant care or research trials
  • History of suffering from any mental/psychiatric disorders:
  • Suffering from a higher risk of burn out, indicated by a total score of more than 2.59 on the Burn out assessment tool (BAT) Suffering from high general fatigue, indicated by a score of more than 57 on the Multidimensional fatigue inventory (MFI) Suffering from depression, indicated by a score of more than16 on the Beck depression inventory-II (BDI-II)
  • Use of medication Chronic use with an exception for contraceptives Prescribed medication in between or before trials Use of non-prescribed occasional medication 24 hours prior each trial
  • Use of caffeine and heavy efforts 24 hours prior each trial
  • Suffering from colour vision deficiencies

Arms & Interventions

Mental fatigue group

Intervention: Reboxetine Pill

Mental fatigue group

Intervention: Methylphenidate Oral Product

Physical fatigue group

Intervention: Reboxetine Pill

Physical fatigue group

Intervention: Methylphenidate Oral Product

Combined group

Intervention: Reboxetine Pill

Combined group

Intervention: Methylphenidate Oral Product

Outcomes

Primary Outcomes

Number of repetitions

Time Frame: 30 minutes

Number of repetitions during knee extension task

Electromyography

Time Frame: 60 minutes

Target muscles are rectus femoris and vastus lateralis (median frequency)

Accuracy

Time Frame: 60 minutes

Accuracy of correct answers during Stroop task

Electroencephalography (spectral analysis)

Time Frame: 80 minutes

measurement of cortical activity with 64 channels (spectral density in alpha, beta, gamma, delta, theta)

Reaction time

Time Frame: 60 minutes

Reaction time for answers during Stroop task

Electroencephalography (event related potentials)

Time Frame: 80 minutes

measurement of cortical activity with 64 channels (event related potentials)

Secondary Outcomes

  • The Brunel Mood Scale (BRUMS)(5 minutes)
  • Motivation with visual analog score (Moti-VAS)(1 minute)
  • Subjective feeling of physical fatigue with visual analog score (P-VAS)(1 minute)
  • Karolinska Sleepiness Scale (KSS)(5 minutes)
  • Heart Rate(60 minutes)
  • Perceived stress scale questionnaire (PSS-10)(5 minites)
  • the international physical activity questionnaire short form (IPAQ-SF)(2 minutes)
  • The National Aeronautics and Space Administration Task Load Index (NASA-TLX)(3 minutes)
  • Subjective feeling of Mental Fatigue with visual analog score (M-VAS)(1 minute)
  • Internal load of the physical performance (CR100 RPE)(30 minutes)
  • Lactate concentration(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials